Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo.
Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, Zhao Y, Yuan Y, Deng Z, Tang H.
Zhong L, et al. Among authors: yuan y.
Theranostics. 2021 Apr 19;11(13):6393-6406. doi: 10.7150/thno.53121. eCollection 2021.
Theranostics. 2021.
PMID: 33995664
Free PMC article.